IDEXX Laboratories IncIDXX

IDXX current price
$414.52-1.54%

Capital at risk.

1W
-7.44%
1M
-12.09%
3M
-10.94%
6M
-14.60%
1Y
-1.54%
MAX
+465.27%
About IDEXX Laboratories Inc
Ticker
info
IDXX
Trading on
info
NASDAQ
ISIN
info
US45168D1046
Industry
info
Diagnostics & Research
Sector
info
Healthcare
CEO
info
Jonathan J. Mazelsky
Headquarters
info
One IDEXX Drive, Westbrook, ME, United States, 04092
Employees
info
11,000
Website
info
idexx.com
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
Metrics
BasicAdvanced
Market cap
info
$33.9B
P/E ratio
info
40.05
EPS
info
$10.35
Dividend Yield
info
0.00%
Beta
info
1.33
Forward P/E ratio
info
36.63
EBIDTA
info
$1.3B
Ex dividend date
info
-
Price & volume
Market cap
info
$33.9B
Average daily volume
info
0.7M
90-day return
info
-10.94%
30-day return
info
-12.09%
7-day return
info
-7.44%
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
$0.00
Payout ratio
info
0.00%
Valuation
P/E ratio
info
40.05
Forward P/E
info
36.63
PEG ratio
info
4.37
Trailing P/E
info
40.05
Price to sales
info
8.83
Price to book
info
20.99
Earnings
EPS
info
$10.35
EPS estimate (current quarter)
info
$2.68
EPS estimate (next quarter)
info
$2.52
EBITDA
info
$1.3B
Revenues (TTM)
info
$3.84B
Revenues per share (TTM)
info
$46.45
Technicals
Beta
info
1.33
52-week High
info
$583.39
52-week Low
info
$404.74
50-day moving average
info
$478.89
200-day moving average
info
$503.44
Short ratio
info
5.69
Short %
info
3.58%
Management effectiveness
ROE (TTM)
info
59.42%
ROA (TTM)
info
22.79%
Profit margin
info
22.53%
Gross profit margin
info
$2B
Operating margin
info
37.46%
Growth
Quarterly earnings growth (YoY)
info
10.70%
Quarterly revenue growth (YoY)
info
6.60%
Share stats
Outstanding Shares
info
$81.9M
Float
info
$81M
Insiders %
info
0.94%
Institutions %
info
96.42%
Analyst Insights & forecasts
info

47% Buy

38% Hold

15% Sell

Based on information from 13 analysts.

Average price target

info
$508.59
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$2.53
$2.37
6.75%
Q3 • 23Beat
$2.32
$2.12
9.43%
Q4 • 23Beat
$2.81
$2.67
5.24%
Q1 • 24Beat
$3.02
$2.88
4.86%
Q2 • 24Beat
$2.80
$2.68
4.48%
Q3 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$1B
$203M
20.26%
Q2 • 24
$976M
$233M
23.87%
Q3 • 24
2.79%
14.53%
17.82%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$3.41B
$1.83B
53.72%
Q2 • 24
$3.35B
$1.73B
51.71%
Q3 • 24
1.88%
5.55%
3.75%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$248M
$-32.9M
$-210M
$215M
Q2 • 24
$220M
-
$-291M
$192M
Q3 • 24
11.37%
-
38.40%
10.71%
QoQ growth
QuarterlyAnnual
Sentiment analysis

-1.5

Greed

+1.5

0.35

Last 30 days

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a IDEXX Laboratories Inc share?
Collapse

IDEXX Laboratories Inc shares are currently traded for $414.52 per share.

How many shares does IDEXX Laboratories Inc have?
Collapse

IDEXX Laboratories Inc currently has $81.9M shares.

Does IDEXX Laboratories Inc pay dividends?
Collapse

No, IDEXX Laboratories Inc doesn't pay dividends.

What is IDEXX Laboratories Inc 52 week high?
Collapse

IDEXX Laboratories Inc 52 week high is $583.39.

What is IDEXX Laboratories Inc 52 week low?
Collapse

IDEXX Laboratories Inc 52 week low is $404.74.

What is the 200-day moving average of IDEXX Laboratories Inc?
Collapse

IDEXX Laboratories Inc 200-day moving average is $503.44.

Who is IDEXX Laboratories Inc CEO?
Collapse

The CEO of IDEXX Laboratories Inc is Jonathan J. Mazelsky.

How many employees IDEXX Laboratories Inc has?
Collapse

IDEXX Laboratories Inc has 11,000 employees.

What is the market cap of IDEXX Laboratories Inc?
Collapse

The market cap of IDEXX Laboratories Inc is $33.9B.

What is the P/E of IDEXX Laboratories Inc?
Collapse

The current P/E of IDEXX Laboratories Inc is 40.05.

What is the EPS of IDEXX Laboratories Inc?
Collapse

The EPS of IDEXX Laboratories Inc is $10.35.

What is the PEG Ratio of IDEXX Laboratories Inc?
Collapse

The PEG Ration of IDEXX Laboratories Inc is 4.37.

What do analysts say about IDEXX Laboratories Inc?
Collapse

According to the analysts IDEXX Laboratories Inc is considered a buy.